| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 7 |
| 1 | ASPIRIN 325 MG | 7 |
| 2 | ASPIRIN 81 MG | 7 |
| 3 | CLOPIDOGREL | 7 |
| 4 | OXALIPLATIN | 7 |
| 5 | CLOPIDOGREL BISULFATE | 6 |
| 6 | FLUOROURACIL | 5 |
| 7 | FLUOROURACIL CREAM, 0.5% | 5 |
| 8 | METHYLPREDNISOLONE | 4 |
| 9 | ALTEPLASE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | THROMBIN HUMAN AND FIBRINOGEN | 1 | 0.0030 |
| 1 | ESTRADIOL AND NORETHINDRONE ACETATE | 1 | 0.0026 |
| 2 | EPTIFIBATIDE | 1 | 0.0013 |
| 3 | FENFLURAMINE | 3 | 0.0006 |
| 4 | PYRIDOXINE HYDROCHLORIDE | 1 | 0.0004 |
| 5 | DOPAMINE HYDROCHLORIDE | 1 | 0.0003 |
| 6 | PROPAFENONE | 1 | 0.0002 |
| 7 | NITRIC OXIDE | 1 | 0.0002 |
| 8 | METHYLDOPA | 1 | 0.0002 |
| 9 | ALTEPLASE | 3 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 1 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 1 | 0.0002 |
| 2 | Vasopressin V2 Receptor Antagonist [EPC] | 2 | 0.0001 |
| 3 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 4 | P2Y12 Platelet Inhibitor [EPC] | 8 | 0.0001 |
| 5 | Orexin Receptor Antagonist [EPC] | 1 | 0.0001 |
| 6 | Androgen [EPC] | 1 | 0.0000 |
| 7 | Platinum-based Drug [EPC] | 7 | 0.0000 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 5 | 0.0000 |
| 9 | Antidote [EPC] | 1 | 0.0000 |